Clover Corporation Limited Logo

Clover Corporation Limited

CLV.AX

(2.0)
Stock Price

0,49 AUD

2.33% ROA

2.91% ROE

47.93x PER

Market Cap.

91.014.455,00 AUD

15.49% DER

1.38% Yield

3.07% NPM

Clover Corporation Limited Stock Analysis

Clover Corporation Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Clover Corporation Limited Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a minimal amount of debt (17%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

2 Dividend

With a solid track record of dividend payments over the past five years, the company has established itself as a dependable choice for investors seeking consistent income.

3 ROE

ROE in an average range (9.53%) suggests satisfactory profitability and decent utilization of shareholders' equity.

4 ROA

The stock's ROA (7.36%) indicates that it's doing well in making money from the things it owns. This makes it a good option to invest and make consistent profits.

5 PBV

The stock's PBV ratio (2.06x) indicates a justifiable valuation, presenting a compelling choice for investors seeking reasonable returns.

6 Buffet Intrinsic Value

The company's stock presents an enticing opportunity as it appears undervalued (9) by Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

7 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

8 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

9 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

10 Graham Number

The company's Graham number suggests that its stock price is overestimated, implying that it may not be a promising investment opportunity.

11 Dividend Growth

The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.

Clover Corporation Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Clover Corporation Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Clover Corporation Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Clover Corporation Limited Revenue
Year Revenue Growth
1997 4.794.000
1998 0 0%
1999 9.338.000 100%
2000 0 0%
2001 8.840.000 100%
2002 9.654.000 8.43%
2003 11.444.000 15.64%
2004 17.470.000 34.49%
2005 14.959.000 -16.79%
2006 18.037.000 17.06%
2007 16.650.000 -8.33%
2008 21.697.000 23.26%
2009 21.498.000 -0.93%
2010 34.937.000 38.47%
2012 38.387.000 8.99%
2013 44.098.000 12.95%
2014 27.190.000 -62.18%
2015 29.921.000 9.13%
2016 42.920.000 30.29%
2017 47.864.000 10.33%
2018 62.961.000 23.98%
2019 76.682.000 17.89%
2020 88.281.000 13.14%
2021 88.281.000 0%
2021 60.505.000 -45.91%
2022 70.660.000 14.37%
2023 79.875.000 11.54%
2024 109.284.000 26.91%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Clover Corporation Limited Research and Development Expenses
Year Research and Development Expenses Growth
1997 0
1998 0 0%
1999 29.000 100%
2000 0 0%
2001 1.401.000 100%
2002 709.000 -97.6%
2003 244.000 -190.57%
2004 330.000 26.06%
2005 166.000 -98.8%
2006 1.075.000 84.56%
2007 907.000 -18.52%
2008 705.000 -28.65%
2009 568.000 -24.12%
2010 1.126.000 49.56%
2012 1.501.000 24.98%
2013 1.846.000 18.69%
2014 1.923.000 4%
2015 1.598.000 -20.34%
2016 1.162.000 -37.52%
2017 1.113.000 -4.4%
2018 1.518.000 26.68%
2019 1.750.000 13.26%
2020 2.195.000 20.27%
2021 2.195.000 0%
2021 1.791.000 -22.56%
2022 1.857.000 3.55%
2023 2.572.000 27.8%
2024 7.968.000 67.72%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Clover Corporation Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
1997 0
1998 0 0%
1999 20.000 100%
2000 0 0%
2001 1.765.000 100%
2002 1.988.000 11.22%
2003 862.000 -130.63%
2004 1.166.000 26.07%
2005 1.424.000 18.12%
2006 2.028.000 29.78%
2007 2.054.000 1.27%
2008 2.800.000 26.64%
2009 2.758.000 -1.52%
2010 2.702.000 -2.07%
2012 3.204.000 15.67%
2013 3.261.000 1.75%
2014 2.834.000 -15.07%
2015 2.548.000 -11.22%
2016 2.454.000 -3.83%
2017 2.821.000 13.01%
2018 4.184.000 32.58%
2019 4.989.000 16.14%
2020 5.361.000 6.94%
2021 5.361.000 0%
2021 4.742.000 -13.05%
2022 4.557.000 -4.06%
2023 5.514.000 17.36%
2024 10.716.000 48.54%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Clover Corporation Limited EBITDA
Year EBITDA Growth
1997 -537.000
1998 -44.000 -1120.45%
1999 143.000 130.77%
2000 -253.000 156.52%
2001 -4.836.000 94.77%
2002 -4.769.000 -1.4%
2003 1.401.000 440.4%
2004 1.889.000 25.83%
2005 1.070.000 -76.54%
2006 1.032.000 -3.68%
2007 1.296.000 20.37%
2008 3.043.000 57.41%
2009 3.593.000 15.31%
2010 11.120.000 67.69%
2012 7.284.000 -52.66%
2013 8.193.000 11.09%
2014 1.788.000 -358.22%
2015 574.000 -211.5%
2016 3.261.000 82.4%
2017 6.056.000 46.15%
2018 10.652.000 43.15%
2019 13.995.000 23.89%
2020 19.043.000 26.51%
2021 18.244.000 -4.38%
2021 10.227.000 -78.39%
2022 11.951.000 14.43%
2023 10.880.000 -9.84%
2024 1.916.000 -467.85%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Clover Corporation Limited Gross Profit
Year Gross Profit Growth
1997 4.794.000
1998 0 0%
1999 9.338.000 100%
2000 0 0%
2001 1.120.000 100%
2002 1.376.000 18.6%
2003 3.493.000 60.61%
2004 4.865.000 28.2%
2005 5.358.000 9.2%
2006 6.622.000 19.09%
2007 5.956.000 -11.18%
2008 7.532.000 20.92%
2009 8.199.000 8.14%
2010 13.372.000 38.69%
2012 15.181.000 11.92%
2013 15.476.000 1.91%
2014 7.919.000 -95.43%
2015 6.043.000 -31.04%
2016 8.663.000 30.24%
2017 11.585.000 25.22%
2018 18.247.000 36.51%
2019 23.920.000 23.72%
2020 29.715.000 19.5%
2021 29.715.000 0%
2021 18.238.000 -62.93%
2022 21.655.000 15.78%
2023 23.738.000 8.77%
2024 29.448.000 19.39%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Clover Corporation Limited Net Profit
Year Net Profit Growth
1997 -684.000
1998 -65.000 -952.31%
1999 -154.000 57.79%
2000 -299.000 48.49%
2001 -4.845.000 93.83%
2002 -5.572.000 13.05%
2003 -143.000 -3796.5%
2004 -266.000 46.24%
2005 -174.000 -52.87%
2006 453.000 138.41%
2007 635.000 28.66%
2008 4.135.000 84.64%
2009 3.082.000 -34.17%
2010 -967.000 418.72%
2012 4.371.000 122.12%
2013 6.078.000 28.08%
2014 967.000 -528.54%
2015 100.000 -867%
2016 2.213.000 95.48%
2017 3.639.000 39.19%
2018 7.588.000 52.04%
2019 10.101.000 24.88%
2020 12.487.000 19.11%
2021 12.487.000 0%
2021 6.004.000 -107.98%
2022 7.133.000 15.83%
2023 6.205.000 -14.96%
2024 -2.572.000 341.25%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Clover Corporation Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1997 0
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Clover Corporation Limited Free Cashflow
Year Free Cashflow Growth
1997 0
1999 -446.000 100%
2000 -1.997.000 77.67%
2001 -3.535.000 43.51%
2002 -163.000 -2068.71%
2003 -95.000 -71.58%
2004 -209.000 54.55%
2005 -49.000 -326.53%
2006 -734.000 93.32%
2007 -441.000 -66.44%
2008 -527.000 16.32%
2009 -326.000 -61.66%
2010 -193.000 -68.91%
2012 -1.894.000 89.81%
2013 2.291.000 182.67%
2014 3.018.000 24.09%
2015 2.348.000 -28.53%
2016 -82.000 2963.41%
2017 -1.075.000 92.37%
2018 -145.000 -641.38%
2019 4.683.000 103.1%
2020 6.105.000 23.29%
2021 6.397.000 4.56%
2021 -139.000 4702.16%
2022 4.508.000 103.08%
2023 5.097.000 11.56%
2024 -4.002.000 227.36%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Clover Corporation Limited Operating Cashflow
Year Operating Cashflow Growth
1997 0
1999 -107.000 100%
2000 0 0%
2001 -3.260.000 100%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2012 0 0%
2013 2.526.000 100%
2014 3.198.000 21.01%
2015 3.106.000 -2.96%
2016 -63.000 5030.16%
2017 -595.000 89.41%
2018 4.081.000 114.58%
2019 4.791.000 14.82%
2020 6.661.000 28.07%
2021 8.228.000 19.04%
2021 0 0%
2022 5.934.000 100%
2023 6.736.000 11.91%
2024 -3.059.000 320.2%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Clover Corporation Limited Capital Expenditure
Year Capital Expenditure Growth
1997 0
1999 339.000 100%
2000 1.997.000 83.02%
2001 275.000 -626.18%
2002 163.000 -68.71%
2003 95.000 -71.58%
2004 209.000 54.55%
2005 49.000 -326.53%
2006 734.000 93.32%
2007 441.000 -66.44%
2008 527.000 16.32%
2009 326.000 -61.66%
2010 193.000 -68.91%
2012 1.894.000 89.81%
2013 235.000 -705.96%
2014 180.000 -30.56%
2015 758.000 76.25%
2016 19.000 -3889.47%
2017 480.000 96.04%
2018 4.226.000 88.64%
2019 108.000 -3812.96%
2020 556.000 80.58%
2021 1.831.000 69.63%
2021 139.000 -1217.27%
2022 1.426.000 90.25%
2023 1.639.000 13%
2024 943.000 -73.81%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Clover Corporation Limited Equity
Year Equity Growth
1997 0
1998 0 0%
1999 0 0%
2000 26.862.000 100%
2001 22.126.000 -21.4%
2002 16.554.000 -33.66%
2003 17.358.000 4.63%
2004 19.013.000 8.7%
2005 22.225.000 14.45%
2006 22.761.000 2.35%
2007 23.668.000 3.83%
2008 26.957.000 12.2%
2009 28.274.000 4.66%
2010 25.627.000 -10.33%
2012 29.900.000 14.29%
2013 32.409.000 7.74%
2014 30.134.000 -7.55%
2015 29.388.000 -2.54%
2016 30.214.000 2.73%
2017 32.576.000 7.25%
2018 38.145.000 14.6%
2019 45.141.000 15.5%
2020 57.569.000 21.59%
2021 58.416.000 1.45%
2022 63.040.000 7.34%
2023 67.151.000 6.12%
2024 67.070.000 -0.12%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Clover Corporation Limited Assets
Year Assets Growth
1997 0
1998 0 0%
1999 0 0%
2000 28.670.000 100%
2001 26.240.000 -9.26%
2002 20.648.000 -27.08%
2003 20.938.000 1.39%
2004 22.203.000 5.7%
2005 24.594.000 9.72%
2006 25.398.000 3.17%
2007 26.367.000 3.68%
2008 31.468.000 16.21%
2009 31.581.000 0.36%
2010 31.746.000 0.52%
2012 39.059.000 18.72%
2013 41.484.000 5.85%
2014 39.498.000 -5.03%
2015 36.560.000 -8.04%
2016 39.821.000 8.19%
2017 42.641.000 6.61%
2018 52.050.000 18.08%
2019 74.751.000 30.37%
2020 81.486.000 8.27%
2021 78.732.000 -3.5%
2022 90.769.000 13.26%
2023 86.202.000 -5.3%
2024 84.392.000 -2.14%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Clover Corporation Limited Liabilities
Year Liabilities Growth
1997 0
1998 0 0%
1999 0 0%
2000 1.808.000 100%
2001 4.114.000 56.05%
2002 4.094.000 -0.49%
2003 3.580.000 -14.36%
2004 3.190.000 -12.23%
2005 2.369.000 -34.66%
2006 2.637.000 10.16%
2007 2.699.000 2.3%
2008 4.511.000 40.17%
2009 3.307.000 -36.41%
2010 6.119.000 45.96%
2012 9.159.000 33.19%
2013 9.075.000 -0.93%
2014 9.364.000 3.09%
2015 7.172.000 -30.56%
2016 9.607.000 25.35%
2017 10.065.000 4.55%
2018 13.905.000 27.62%
2019 29.610.000 53.04%
2020 23.917.000 -23.8%
2021 20.316.000 -17.72%
2022 27.729.000 26.73%
2023 19.051.000 -45.55%
2024 17.322.000 -9.98%

Clover Corporation Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.37
Net Income per Share
0.01
Price to Earning Ratio
47.93x
Price To Sales Ratio
1.45x
POCF Ratio
20.25
PFCF Ratio
40.49
Price to Book Ratio
1.37
EV to Sales
1.42
EV Over EBITDA
19.15
EV to Operating CashFlow
19.57
EV to FreeCashFlow
39.65
Earnings Yield
0.02
FreeCashFlow Yield
0.02
Market Cap
0,09 Bil.
Enterprise Value
0,09 Bil.
Graham Number
0.32
Graham NetNet
0.12

Income Statement Metrics

Net Income per Share
0.01
Income Quality
2.37
ROE
0.03
Return On Assets
0.02
Return On Capital Employed
0.05
Net Income per EBT
0.64
EBT Per Ebit
0.83
Ebit per Revenue
0.06
Effective Tax Rate
0.26

Margins

Sales, General, & Administrative to Revenue
0.08
Research & Developement to Revenue
0.04
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.27
Operating Profit Margin
0.06
Pretax Profit Margin
0.05
Net Profit Margin
0.03

Dividends

Dividend Yield
0.01
Dividend Yield %
1.38
Payout Ratio
1.3
Dividend Per Share
0.01

Operating Metrics

Operating Cashflow per Share
0.03
Free CashFlow per Share
0.01
Capex to Operating CashFlow
0.51
Capex to Revenue
0.04
Capex to Depreciation
2.26
Return on Invested Capital
0.03
Return on Tangible Assets
0.02
Days Sales Outstanding
79.73
Days Payables Outstanding
40.7
Days of Inventory on Hand
236.75
Receivables Turnover
4.58
Payables Turnover
8.97
Inventory Turnover
1.54
Capex per Share
0.01

Balance Sheet

Cash per Share
0,07
Book Value per Share
0,40
Tangible Book Value per Share
0.39
Shareholders Equity per Share
0.4
Interest Debt per Share
0.07
Debt to Equity
0.15
Debt to Assets
0.12
Net Debt to EBITDA
-0.4
Current Ratio
5.79
Tangible Asset Value
0,07 Bil.
Net Current Asset Value
0,04 Bil.
Invested Capital
61494000
Working Capital
0,05 Bil.
Intangibles to Total Assets
0.02
Average Receivables
0,01 Bil.
Average Payables
0,00 Bil.
Average Inventory
31784000
Debt to Market Cap
0.11

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Clover Corporation Limited Dividends
Year Dividends Growth
2004 0
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

Clover Corporation Limited Profile

About Clover Corporation Limited

Clover Corporation Limited refines and sells natural oils in Australia, New Zealand, Asia, Europe, and the Americas. It also engages in the production of encapsulated products; and research and product development of functional food and infant nutrition ingredients. In addition, the company offers Nu-Mega Hi docosahexaenoic tuna oils for use in infant formula and pharmaceutical products; Ocean Gold refined tuna oils; Nu-Mega Driphorm powders that are used in a range of infant formula, follow-on formula, growing up milks, and food applications; and Nu-Mega Driphorm HA for non-dairy applications. Further, it provides products in the areas of active living-immune system and sports, healthy living–brain and heart, and starting out-infant and child. The company was incorporated in 1988 and is headquartered in Altona North, Australia.

CEO
Mr. Peter J. Davey GAICD, grad
Employee
60
Address
39 Pinnacle Road
Altona North, 3025

Clover Corporation Limited Executives & BODs

Clover Corporation Limited Executives & BODs
# Name Age
1 S. Poothong
Chief Commercial Officer
70
2 Ms. Anne Roach
General Manager of People & Culture
70
3 Mr. Andrew G. M. Allibon C.A.
Chief Financial Officer & Company Secretary
70
4 Mr. Peter J. Davey GAICD, gradDip Bus., MBA
Chief Executive Officer, MD & Executive Director
70
5 Mr. David Pierotti
Director of Operations
70
6 Mr. Bassam Hallak
Director of Sales & Marketing
70

Clover Corporation Limited Competitors